RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 164 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $441,000 | -83.5% | 390,066 | -56.5% | 0.12% | -82.8% |
| Q1 2022 | $2,679,000 | +15.0% | 896,100 | +1.9% | 0.70% | +19.1% |
| Q4 2021 | $2,329,000 | -20.7% | 879,000 | +8.7% | 0.59% | -24.8% |
| Q3 2021 | $2,937,000 | +177.3% | 809,000 | +231.6% | 0.78% | +252.5% |
| Q2 2021 | $1,059,000 | +12.4% | 244,000 | -11.4% | 0.22% | -0.9% |
| Q1 2021 | $942,000 | +226.0% | 275,500 | +74.7% | 0.22% | +168.7% |
| Q2 2020 | $289,000 | +17.5% | 157,700 | 0.0% | 0.08% | -19.4% |
| Q1 2020 | $246,000 | -27.0% | 157,700 | 0.0% | 0.10% | -11.2% |
| Q4 2019 | $337,000 | +14.2% | 157,700 | 0.0% | 0.12% | +4.5% |
| Q3 2019 | $295,000 | -17.8% | 157,700 | +14.6% | 0.11% | -17.8% |
| Q2 2019 | $359,000 | +1.4% | 137,600 | 0.0% | 0.14% | -11.8% |
| Q1 2019 | $354,000 | +12.0% | 137,600 | 0.0% | 0.15% | -2.5% |
| Q4 2018 | $316,000 | -28.5% | 137,600 | 0.0% | 0.16% | -13.7% |
| Q3 2018 | $442,000 | +13.6% | 137,600 | 0.0% | 0.18% | 0.0% |
| Q2 2018 | $389,000 | -87.8% | 137,600 | -84.7% | 0.18% | -88.3% |
| Q1 2018 | $3,193,000 | -16.3% | 901,933 | -8.3% | 1.55% | -24.4% |
| Q4 2017 | $3,816,000 | +238.9% | 983,478 | +121.8% | 2.06% | +194.0% |
| Q3 2017 | $1,126,000 | -7.0% | 443,478 | 0.0% | 0.70% | -19.1% |
| Q2 2017 | $1,211,000 | -22.7% | 443,478 | -6.3% | 0.86% | -34.8% |
| Q1 2017 | $1,567,000 | +25.6% | 473,478 | +39.3% | 1.32% | +52.5% |
| Q3 2016 | $1,248,000 | -69.7% | 340,000 | -81.6% | 0.87% | -73.4% |
| Q2 2016 | $4,119,000 | +5.5% | 1,847,087 | -1.6% | 3.26% | -3.0% |
| Q1 2016 | $3,903,000 | +16.1% | 1,876,492 | +69.1% | 3.37% | +12.3% |
| Q4 2015 | $3,363,000 | +22.7% | 1,109,740 | 0.0% | 3.00% | +10.2% |
| Q3 2015 | $2,741,000 | -23.0% | 1,109,740 | 0.0% | 2.72% | -9.7% |
| Q2 2015 | $3,562,000 | -10.1% | 1,109,740 | 0.0% | 3.01% | -1.0% |
| Q1 2015 | $3,962,000 | +133.1% | 1,109,740 | +48.1% | 3.04% | +126.2% |
| Q4 2014 | $1,700,000 | – | 749,066 | – | 1.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
| Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
| CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
| SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
| Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
| Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
| DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
| KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
| Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |